Alisa Kokorina | Biology | Women Researcher Award

Women Researcher Award

Alisa Kokorina

Alisa Kokorina, affiliated with the Skolkovo Institute of Science and Technology, is a researcher recognized for contributions to biology, neurotechnology, and post-COVID-19 clinical outcome research. Her scholarly activities reflect interdisciplinary collaboration involving rehabilitation technologies, neuroscience, and international healthcare consensus studies.[1]

Alisa Kokorina
Affiliation Skolkovo Institute of Science and Technology
Country Russia
Scopus ID 57438603500
Documents 2
Citations 288
h-index 2
Subject Area Biology
Event Scientific World Research Awards
ORCID 0000-0001-5325-5830

Her publications address rehabilitation science, clinical outcome standardization, and brain-computer interface methodologies. Through participation in international Delphi consensus initiatives, Kokorina has contributed to the development of standardized approaches for studying post-COVID-19 conditions and rehabilitation outcomes.[2]

Abstract

Alisa Kokorina is associated with interdisciplinary scientific research focusing on biology, neurotechnology, and clinical rehabilitation studies. Her scholarly work includes participation in international investigations related to post-COVID-19 condition assessment and the development of standardized clinical outcome sets. She has contributed to research on brain-computer interface technologies and lower limb rehabilitation systems integrating electrical spinal stimulation methodologies. Publications connected to her research profile appear in internationally recognized journals such as The Lancet Respiratory Medicine, BMC Medicine, and Frontiers in Human Neuroscience. These contributions demonstrate collaborative engagement in evidence-based healthcare and rehabilitation science research initiatives.[2]

Keywords

Biology, Neurotechnology, Brain-Computer Interface, Rehabilitation Science, Post-COVID-19 Research, Clinical Outcomes, Neuroscience, Delphi Consensus.

Introduction

The increasing integration of neurotechnology and healthcare analytics has expanded interdisciplinary biomedical research. Alisa Kokorina has participated in collaborative studies involving rehabilitation systems, neuroscience, and post-COVID-19 clinical frameworks. Her research activity reflects the importance of international scientific cooperation in addressing rehabilitation and long-term healthcare challenges.[3]

Research Profile

Kokorina’s academic profile includes publications indexed through ORCID and Scopus databases. Her documented research areas involve neurorehabilitation systems, post-stroke rehabilitation, and consensus-based clinical outcome measurement studies. She is affiliated with international collaborative research involving medical and rehabilitation sciences.[1]

Research Contributions

Among her noted contributions is participation in studies examining core outcome measurement instruments for adults with post-COVID-19 conditions. Additional work explored rehabilitation methods using visuomotor transformation-based brain-computer interfaces and spinal cord electrical stimulation technologies.[4]

Publications

  • Case Report: post-stroke rehabilitation with a visuomotor transformation-based brain-computer interface, Frontiers in Human Neuroscience, 2026.
  • A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research, Lancet Respiratory Medicine, 2022.
  • Novel method for lower limb rehabilitation based on brain-computer interface and transcutaneous spinal cord electrical stimulation, CNN Conference Proceedings, 2022.

Research Impact

The citation record associated with Kokorina’s research profile indicates scholarly visibility within rehabilitation and biomedical research communities. Her collaborative publications support the advancement of standardized methodologies and interdisciplinary rehabilitation research approaches.[5]

Award Suitability

The Women Researcher Award recognizes emerging and established researchers contributing to scientific innovation and collaborative advancement. Kokorina’s involvement in neurotechnology, rehabilitation science, and post-COVID-19 outcome studies demonstrates interdisciplinary engagement aligned with the objectives of international scientific recognition programs.

Conclusion

Alisa Kokorina’s academic profile reflects contributions to biomedical and rehabilitation sciences through collaborative international research. Her participation in consensus studies and neurotechnology-based rehabilitation investigations highlights ongoing engagement with contemporary healthcare and biological research challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Alisa Kokorina, Author ID 57438603500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57438603500
  2. ORCID. (2026). Alisa Kokorina ORCID Record.
    https://orcid.org/0000-0001-5325-5830
  3. Munblit, D. et al. (2022). A core outcome set for post-COVID-19 condition in adults. Lancet Respiratory Medicine.
    https://doi.org/10.1016/S2213-2600(22)00169-2
  4. Ninenko, I. et al. (2022). Novel method for lower limb rehabilitation based on brain-computer interface.
    https://doi.org/10.1109/cnn56452.2022.9912550
  5. Kokorina, A. et al. (2026). Case Report: post-stroke rehabilitation with a visuomotor transformation-based brain-computer interface.
    https://doi.org/10.3389/fnhum.2026.1774409

Bushra Bushra | Biology | Research Excellence Award

Dr. Bushra Bushra | Biology | Research Excellence Award

Post-doctoral researcher | Shantou University Medical College | China

Dr. Bushra Bushra is a postdoctoral researcher focused on fisheries science, parasitology, and molecular biology, with expertise in aquatic disease management. Her research centers on Cryptocaryon irritans, advancing detection and antiparasitic strategies in aquaculture. She is skilled in PCR, transcriptomics, and metabolomics, contributing to impactful scientific publications. She has earned recognition through her research contributions. According to Scopus, she has 31 citations, 6 documents, and an h-index of 3, reflecting her growing academic influence.

 

Citation Metrics (Scopus)

31
25
15
5
0

Citations

31

Documents

6

h-index

3

Citations

Documents

h-index

View Google Scholar Profile View ResearchGate Profile

Featured Publications

 

Hengbin Wang | Biology | Research Excellence Award

Prof. Hengbin Wang | Biology | Research Excellence Award

PhD | Virginia Commonwealth University | United States

Prof. Hengbin Wang is a highly accomplished biomedical researcher specializing in epigenetics, chromatin biology, and cancer molecular mechanisms, with a strong focus on how chromatin remodeling and histone modifications regulate gene expression, genome stability, and disease progression. His research interests include Polycomb repressive complexes (PRC1), histone ubiquitination and methylation, chromatin remodelers such as RSF1, non-coding RNAs, mitochondrial regulation, and translational cancer biology, particularly in esophageal and pancreatic cancers. He possesses advanced research skills in molecular and cellular biology, epigenomic analysis, cancer genomics, functional assays, therapeutic target validation, and drug-sensitization strategies. Prof. Wang’s scientific excellence has been recognized through competitive research grants, high-impact publications, and international peer recognition, reflecting notable awards and professional honors in his field. According to Scopus, he has authored 70 documents, received 11,684 citations, and holds an h-index of 32, underscoring his significant and sustained research impact. Overall, his work bridges fundamental chromatin regulation with clinically relevant cancer therapeutics and precision medicine.

 

Citation Metrics (Scopus)

11684
9000
6000
3000
1000
500
100
0

Citations

11,684

Documents

70

h-index

32

Citations

Documents

h-index

View Scopus  View Google Scholar View ResearchGate

Featured Publications

 

Kai Yuan | Biology | Research Excellence Award

Assoc. Prof. Dr. Kai Yuan | Biology | Research Excellence Award

Associate Professor | Peking University | China

Assoc. Prof. Dr. Kai Yuan is an internationally recognized researcher at Peking University whose work significantly advances neuroscience, psychiatric epidemiology, molecular signaling, and translational mental health research. With an exceptional 8,438 citations, 244 Scopus-indexed documents, and a strong h-index of 47, he stands among the most impactful scholars in neurobiology and psychiatric disorder research. His research interests span addiction memory consolidation, brain network dynamics, fMRI-based cognitive and emotional processing, depression and anxiety burden forecasting, cancer cell signaling, neuroimmune mechanisms, and human behavior under stress. Dr. Yuan’s research skills are wide-ranging and include advanced neuroimaging analytics, molecular and cellular assays, biomarker profiling, psychophysiological modeling, machine-learning–based disease prediction, and multidisciplinary clinical collaboration, often demonstrated through publications in high-impact journals such as Nature Communications, Translational Psychiatry, BMC Medicine, Communications Biology, and Journal of Affective Disorders. Although Scopus Preview does not list formal award entries, Dr. Yuan’s prolific productivity, more than 980 global co-authors, and consistent contributions to open-access, high-visibility research reflect his standing as a leading scientist whose work is frequently recognized by the international research community. His studies on psychiatric disorder mechanisms, memory retrieval-extinction processes, cancer proliferation pathways, and long-term cognitive outcomes of viral infections directly support advancements in clinical treatment strategies, public health decision-making, and precision medicine. In conclusion, Dr. Kai Yuan’s research continues to shape global understanding of the human brain and mental health, providing foundational insights that drive innovation across neuroscience, psychiatry, and biomedical science, while strengthening the scientific infrastructure for future therapeutic breakthroughs.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

  1. Yu, Y. F., Jia, T. Y., Lin, X., Bao, Y. P., Chang, S. H., Sun, J., Gao, T., Shi, J., Ai, S. Z., & Yuan, K.* (2025). Unveiling causal relationship between white matter tracts and psychiatric disorders. Communications Biology, 8(1), 1221.

  2. Xu, A., Yuan, K.#, Xue, S., Lu, W., Wu, X., Liu, W., Xue, Q., Liu, L., Hu, J., Guo, L., Zhang, Y., Hu, X., Chun Wong, G. T., Lu, L., & Huang, C. (2025). Laminin–dystroglycan mediated ferroptosis in hemorrhagic shock and reperfusion-induced cognitive impairment through AMPK/Nrf2. Free Radical Biology and Medicine, 230, 1–16.

  3. Chen, X., Li, Z., Han, Y., Yang, L., Han, Q., Cao, L., Guan, X., Liu, S., Meng, S., Liu, X., Lu, L., Zhang, Z., & Yuan, K.* (2025). A coordinated and enhanced brain network supports the persistence of long-term cocaine memory. Translational Psychiatry, 15(1), 444.

  4. Liu, X.#, Yuan, K.#, Lu, T., Lin, X., Zheng, W., Xue, Y., Shi, J., Lu, L., & Han, Y. (2023). Preventing incubation of drug craving to treat drug relapse: From bench to bedside. Molecular Psychiatry, 28(4), 1415–1429.

  5. Yue, J. L.#, Yuan, K.#, Bao, Y. P., Meng, S. Q., Shi, L., Fang, Q., Guo, X. J., Cao, L., Sun, Y. K., Lu, T. S., Zeng, N., Yan, W., Han, Y., Sun, J., Shi, J., Kosten, T. R., Xue, Y. X., Wu, P., & Lu, L.* (2022). [Title missing—please provide the exact article title to complete APA formatting]. EBioMedicine, 85, 104283.

Assoc. Prof. Dr. Kai Yuan’s pioneering research at the intersection of neuroscience, psychiatry, and translational medicine is advancing global understanding of brain circuitry, mental health disorders, and addiction biology. His work contributes to science by uncovering causal neural mechanisms that shape cognition, behavior, and psychiatric vulnerability, supports society through improved diagnostics and therapeutic strategies for depression, addiction, and neurological injury, and drives global innovation by integrating advanced neuroimaging, molecular signaling, and computational analytics to inform next-generation precision mental healthcare.